Participating Faculty
Introduction: Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
Coronary Heart Disease in the United States
Mechanisms of Acute Coronary Events
Primary Prevention
Pravastatin Event Reduction Analysis
Secondary Prevention
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?
Methods and Mindsets in Pharmacoeconomics
Issues and Controversies in Pharmacoeconomics
Pharmacoeconomics Perspectives: Payers, Providers, and Patients
Assessing the Value and Affordability of Cholesterol Reduction in the Managed Care Setting
CME Quiz
Selected Abstracts
Bibliography
Part I: Scope of the Problem
Part II: Primary Prevention
Part III: Secondary Prevention
Part IV: Pharmacoeconomics
